{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:43:59Z","timestamp":1776084239845,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jdiacomp.2023.108587","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T01:56:46Z","timestamp":1692064606000},"page":"108587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of faster aspart in insulin pumps in children and adolescents with type 1 diabetes mellitus: A single-center study with real-world data"],"prefix":"10.1016","volume":"37","author":[{"given":"Athina","family":"Stamati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Sotiriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meropi","family":"Dimitriadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Christoforidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2023.108587_bb0005","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jama.2021.11165","article-title":"Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001-2017","volume":"326","author":"Lawrence","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0010","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.2337\/dc14-0574","article-title":"The SEARCH for diabetes in youth study: rationale, findings, and future directions","volume":"37","author":"Hamman","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0015","first-page":"139","article-title":"Type 1 diabetes","volume":"176","author":"DiMeglio","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0020","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1089\/dia.2019.0123","article-title":"Efficacy and safety of real-life usage of MiniMed 670G automode in children with type 1 diabetes less than 7 years old","volume":"21","author":"Salehi","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/dia.2019.0142","article-title":"Benefits and barriers of continuous glucose monitoring in young children with type 1 diabetes","volume":"21","author":"Hilliard","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0030","first-page":"316","article-title":"Efficacy and safety of continuous subcutaneous insulin infusion vs. multiple daily injections on type 1 diabetes children: a meta-analysis of randomized control trials","volume":"10","author":"Qin","year":"2018","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2352-4642(20)30339-4","article-title":"Early versus delayed insulin pump therapy in children with newly diagnosed type 1 diabetes: results from the multicentre, prospective diabetes follow-up DPV registry","volume":"5","author":"Kamrath","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0040","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2337\/ds18-0091","article-title":"A clinical overview of insulin pump therapy for the management of diabetes: past, present, and future of intensive therapy","volume":"32","author":"Berget","year":"2019","journal-title":"Diabetes Spectr"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0045","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1463-1326.2012.01580.x","article-title":"The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences","volume":"14","author":"Home","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0050","series-title":"Fiasp, INN-insulin Aspart 2016","volume":"44","author":"CHMP","year":"2016"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0055","author":"Heise"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0060","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1111\/dom.14461","article-title":"Ultra-rapid-acting insulins for adults with diabetes: a systematic review and meta-analysis","volume":"23","author":"Avgerinos","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110144","article-title":"Efficacy and safety of ultra-rapid insulin analogues in insulin pumps in patients with Type 1 Diabetes Mellitus: a systematic review and meta-analysis","volume":"193","author":"Stamati","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.anpedi.2020.11.002","article-title":"The impact of \u201cfaster aspart\u201d on blood glucose control in children and adolescents with type 1 diabetes treated using a sensor-augmented insulin pump","volume":"95","author":"Gonz\u00e1lez de Buitrago Amigo","year":"2021","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0075","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/pedi.12506","article-title":"Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus","volume":"18","author":"Fath","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0080","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1507\/endocrj.EJ20-0116","article-title":"Efficacy and safety of fast-acting insulin as part versus insulin as part in children and adolescents with type 1 diabetes from Japan","volume":"68","author":"Kawamura","year":"2021","journal-title":"Endocr J"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0085","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2337\/dc19-0009","article-title":"Efficacy and safety of fast-acting insulin aspart compared with insulin aspart, both in combination with insulin degludec, in children and adolescents with type 1 diabetes: the onset 7 trial","volume":"42","author":"Bode","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jdiacomp.2023.108587_bb0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/pds.3891","article-title":"Guidelines for good pharmacoepidemiology practice (GPP)","volume":"25","author":"Public Policy Committee","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0095","first-page":"14","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"81","author":"Review","year":"2014","journal-title":"J Am Coll Dent"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0100","doi-asserted-by":"crossref","DOI":"10.2196\/16204","article-title":"PediTools electronic growth chart calculators: applications in clinical care, research, and quality improvement","volume":"22","author":"Chou","year":"2020","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0105","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/dom.13610","article-title":"A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5)","volume":"21","author":"Klonoff","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/dia.2016.0350","article-title":"Improved postprandial glycemic control with faster-acting insulin Aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion","volume":"19","author":"Bode","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0115","series-title":"Can Faster Aspart be used to optimize glycemic control with insulin pump therapy? From expectations to lessons learned after a year of use in the United States","author":"Aleppo","year":"2022"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0120","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s13340-021-00565-8","article-title":"Effect of ultra-rapid insulin aspart on glycemic control in children with type 1 diabetes: the experience of a Portuguese tertiary centre","volume":"13","author":"Costa","year":"2022","journal-title":"Diabetol Int"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0125","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/dmrr.447","article-title":"Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life; and cost-effectiveness","volume":"20","author":"Radermecker","year":"2004","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0130","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s40262-017-0514-8","article-title":"A pooled analysis of clinical pharmacology trials investigating the pharmacokinetic and pharmacodynamic characteristics of fast-acting insulin Aspart in adults with type 1 diabetes","volume":"56","author":"Heise","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0135","series-title":"Ultra-rapid-acting insulins: how fast is really needed?","first-page":"4","volume":"39","author":"Wong","year":"2021"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0140","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1111\/dom.14527","article-title":"Glucose control using fast-acting insulin aspart in a real-world setting: a 1-year, two-centre study in people with type 1 diabetes using continuous glucose monitoring","volume":"23","author":"Billion","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0145","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s40618-022-01745-2","article-title":"Glycemic control after switching to faster aspart in adults with type 1 diabetes","volume":"45","author":"Fadini","year":"2022","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0150","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/dom.13798","article-title":"Use of fast-acting insulin aspart in insulin pump therapy in clinical practice","volume":"21","author":"Evans","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0155","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1111\/dom.14368","article-title":"Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2","volume":"23","author":"Warren","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2023.108587_bb0160","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3390\/jpm13030422","article-title":"Type 1 diabetes mellitus and autoimmune diseases: a critical Review of the association and the application of personalized medicine","volume":"13","author":"Popoviciu","year":"2023","journal-title":"J Pers Med"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687272300185X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687272300185X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:18:05Z","timestamp":1761005885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105687272300185X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S105687272300185X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2023.108587","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of faster aspart in insulin pumps in children and adolescents with type 1 diabetes mellitus: A single-center study with real-world data","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2023.108587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108587"}}